TRANSITION BIO, INC.

Profile

Company Names

TRANSITION BIO, INC.

Addresses

ONE MIFFLIN PLACE, SUITE 400, CAMBRIDGE, MA 02138

Phone Numbers

917-445-5573

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$58,351,426.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-10-11 
$13,265,426.00 
$21,265,426.00 
$8,000,000.00 
Equity 
2
2023-12-22 
$6,000,000.00 
$15,000,000.00 
$9,000,000.00 
Debt 
1
2022-03-24 
$39,086,000.00 
$50,000,000.00 
$10,914,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SAMUEL 
 
COHEN 
DIRECTOR
TRANSITION BIO, INC.   |  MAMA TECHNOLOGIES INC.
SHAAN 
 
GANDHI 
DIRECTOR
DICE MOLECULES HOLDINGS, LLC   |  STRIDEBIO, INC.   |  VIGIL NEUROSCIENCE, INC.   |  GARUDA THERAPEUTICS, INC.   |  CAMP4 THERAPEUTICS CORP   |  TRANSITION BIO, INC.
TUOMAS 
 
KNOWLES 
EXECUTIVE OFFICER, DIRECTOR
TRANSITION BIO, INC.
MARTIN 
 
KULANDER 
EXECUTIVE OFFICER
TRANSITION BIO, INC.
PAXTON 
 
MAJOR 
DIRECTOR
GENERAL AUTOMATION LAB TECHNOLOGIES INC.   |  CHERRYCIRCLE SOFTWARE, INC.   |  KYTOPEN CORP.   |  TRANSITION BIO, INC.   |  ENPLUSONE BIOSCIENCES INC.   |  QBDVISION, INC.
PREET 
 
MAKKAR 
EXECUTIVE OFFICER
TRANSITION BIO, INC.
GEORGE 
 
MARTIN 
EXECUTIVE OFFICER, DIRECTOR
TRANSITION BIO, INC.
GEORGE 
K. 
MARTIN 
DIRECTOR
TRANSITION BIO, INC.
CONNOR 
 
MCDERMOTT 
DIRECTOR
TRANSITION BIO, INC.
GREGORY 
L. 
MILLER 
EXECUTIVE OFFICER, DIRECTOR
TRANSITION BIO, INC.
AL 
 
SANDROCK 
DIRECTOR
TRANSITION BIO, INC.
STEPHANIE 
 
TORRUELLA 
EXECUTIVE OFFICER
TRANSITION BIO, INC.
ROBERT 
 
WEEKS 
DIRECTOR
PROSTEEL HOLDINGS, LLC   |  TRANSITION BIO, INC.
KATHY 
 
YI 
DIRECTOR
TRANSITION BIO, INC.   |  AFFINI-T THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-10-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-11 
2024-01-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-12-22 
2023-03-07
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-24 
2022-04-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#